Cargando…
β-arrestin-2-biased agonism of delta opioid receptors sensitizes transient receptor potential vanilloid type 1 (TRPV1) in primary sensory neurons
Despite advances in understanding the signaling mechanisms involved in the development and maintenance of chronic pain, the pharmacologic treatment of chronic pain has seen little advancement. Agonists at the mu opioid receptor (MOPr) continue to be vital in the treatment of many forms of chronic pa...
Autores principales: | Rowan, Matthew P, Szteyn, Kalina, Doyle, Allison P, Gomez, Ruben, Henry, Michael A, Jeske, Nathaniel A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4131480/ https://www.ncbi.nlm.nih.gov/pubmed/25085415 http://dx.doi.org/10.1186/1744-8069-10-50 |
Ejemplares similares
-
Activation of Mu Opioid Receptors Sensitizes Transient Receptor Potential Vanilloid Type 1 (TRPV1) via β-Arrestin-2-Mediated Cross-Talk
por: Rowan, Matthew P., et al.
Publicado: (2014) -
Vascular Expression of Transient Receptor Potential Vanilloid 1 (TRPV1)
por: Sand, Claire A., et al.
Publicado: (2015) -
Repeat low-level blast exposure increases transient receptor potential vanilloid 1 (TRPV1) and endothelin-1 (ET-1) expression in the trigeminal ganglion
por: Por, Elaine D., et al.
Publicado: (2017) -
Direct activation of Transient Receptor Potential Vanilloid 1(TRPV1) by Diacylglycerol (DAG)
por: Woo, Dong Ho, et al.
Publicado: (2008) -
Identification and Quantification of Transient Receptor Potential Vanilloid 1 (TRPV1) in Equine Articular Tissue
por: vom Braucke, Anne Frank Gallagher, et al.
Publicado: (2020)